针对传统中医药在瘤微环境中的脂质重编程,作为潜在的癌症治疗方法
Qian Zuo1,2, Yingchao Wu1, Yuyu Hu2,3
1State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Heliyon
|May 20, 2024
概括
癌细胞重编程脂质代谢,影响生长和免疫细胞. 传统中医成分显示出调节这些代谢转变的潜力.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 利皮多米克 (Lipidomics) 是一种消化剂.
背景情况:
- 癌细胞表现出代谢重编程,脂质代谢得到了关注.
- 脂管学技术使得瘤中的脂质资料和瘤微环境 (TME) 的详细分析成为可能.
- 传统中医 (TCM) 在癌症治疗中具有历史性的应用,并被探索用于新陈代谢调节.
研究的目的:
- 审查癌症脂质代谢中的关键变化.
- 讨论脂质重编程对TME内的瘤生长,转移和免疫细胞的影响.
- 突出TCM在调节癌症脂质代谢中的作用.
主要方法:
- 文献综述专注于癌症中的脂质代谢.
- 分析脂管学数据及其影响.
- 探索TCM的生物活性成分及其机制.
主要成果:
- 关键的脂质重编程事件包括脂肪酸合成,摄取,氧化 (FAO) 和胆固醇积累.
- 改变的脂质代谢会影响TME内的瘤生长,转移和免疫细胞功能.
- 特定的TCM组件显示出向癌症脂质代谢途径的潜力.
结论:
- 脂质代谢是癌症进展的一个关键,但尚未研究的方面.
- 向癌症脂质代谢提供了治疗机会.
- 通过调节脂质代谢,TCM为开发新型抗癌策略提供了有希望的途径.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
348
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
